JEAN-A'LAYN FRANCO: Open Payments
NPI 1205458809 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,420 in 164 payments from 31 companies in 2025. Trend: 2023 $4,797 · 2024 $5,942 · 2025 $4,420
Food & beverage: $4,420
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $637 |
| AstraZeneca Pharmaceuticals LP | 14 | $449 |
| Alnylam Pharmaceuticals Inc. | 10 | $395 |
| ABBVIE INC. | 7 | $371 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 18 | $364 |
| Amgen Inc. | 10 | $294 |
| E.R. Squibb & Sons, L.L.C. | 21 | $237 |
| Lilly USA, LLC | 4 | $183 |
| Merck Sharp & Dohme LLC | 8 | $162 |
| BridgeBio Pharma, Inc. | 3 | $157 |
Products named: JARDIANCE, Wegovy, Ozempic, REPATHA, AIRSUPRA, AMVUTTRA, VRAYLAR, ELIQUIS.
Industry payments across CT — which companies pay providers there.
